IPAR Inter Parfums Inc

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

☒	Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024.

 

OR

 

☐	Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ___________to ________.

 

Commission File No. 0-16469

 

INTER PARFUMS, INC.

 (Exact name of registrant as specified in its charter)

 

Delaware		13-3275609
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

 

551 Fifth Avenue, New York, New York     10176

(Address of Principal Executive Offices)          (Zip Code)

 

(212) 983-2640

(Registrants telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $.001 par value per share		IPAR		The Nasdaq Stock Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)	Smaller reporting company ☐
	Emerging Growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

At May 7, 2024, there were 32,023,640 shares of common stock, par value $.001 per share, outstanding.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

INDEX

 

			Page Number
Part I.	Financial Information		1
	Item 1.	Financial Statements
		Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023	2
		Consolidated Statements of Income for the Three Months Ended March 31, 2024 and March 31, 2023	3
		Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2024 and March 31, 2023	4
		Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2024 and March 31, 2023	5
		Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and March 31, 2023	6
		Notes to Consolidated Financial Statements	7
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25
	Item 4.	Controls and Procedures	26
Part II.	Other Information		26
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26
	Item 5.	Other Information	26
	Item 6.	Exhibits	27
Signatures

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Part I. Financial Information

 

Item 1.

Financial Statements

 

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, 2023, included in our annual report filed on Form 10-K.

 

The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the entire fiscal year.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

 (In thousands except share and per share data)

 (Unaudited)

 

ASSETS
		March 31, 2024				December 31, 2023
Current assets:
Cash and cash equivalents		$	20,976			$	88,462
Short-term investments			76,078				94,304
Accounts receivable, net			293,075				247,240
Inventories			400,209				371,859
Receivables, other			5,581				7,012
Other current assets			34,258				29,458
Income taxes receivable			2,490				691
Total current assets			832,667				839,026
Property, equipment and leasehold improvements, net			164,165				169,222
Right-of-use assets, net			26,980				28,613
Trademarks, licenses and other intangible assets, net			288,117				296,356
Deferred tax assets			15,726				14,545
Other assets			21,521				21,567
Total assets		$	1,349,176			$	1,369,329
LIABILITIES AND EQUITY
Current liabilities:
Loans payable - banks		$	8,324			$	4,420
Current portion of long-term debt			29,027				29,587
Current portion of lease liabilities			5,928				5,951
Accounts payable – trade			106,219				97,409
Accrued expenses			135,660				178,880
Income taxes payable			17,300				8,498
Total current liabilities			302,458				324,745
Long–term debt, less current portion			115,926				127,897
Lease liabilities, less current portion			22,905				24,517
Equity:
Inter Parfums, Inc. shareholders’ equity:
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued			—				—
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,023,640 and 32,004,660 shares at March 31, 2024 and December 31, 2023, respectively			32				32
Additional paid-in capital			100,309				98,565
Retained earnings			711,043				693,848
Accumulated other comprehensive loss			(50,417	)			(40,188	)
Treasury stock, at cost, 9,981,665 and 9,981,665 shares at March 31, 2024 and December 31, 2023, respectively			(52,864	)			(52,864	)
Total Inter Parfums, Inc. shareholders’ equity			708,103				699,393
Noncontrolling interest			199,784				192,777
Total equity			907,887				892,170
Total liabilities and equity		$	1,349,176			$	1,369,329

 

See notes to consolidated financial statements.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

 (Unaudited)

 

		Three Months Ended March 31,
		2024				2023
Net sales		$	323,963			$	311,723
Cost of sales			121,578				108,766
Gross margin			202,385				202,957
Selling, general and administrative expenses			134,412				112,678
Income from operations			67,973				90,279
Other expenses (income):
Interest expense			1,807				2,357
(Gain) loss on foreign currency			(905	)			759
Interest and investment income			(3,020	)			(5,382	)
Other expense (income)			38				(41	)
Nonoperating Income (Expense)			(2,080	)			(2,307	)
Income before income taxes			70,053				92,586
Income taxes			16,750				21,678
Net income			53,303				70,908
Less:  Net income attributable to the noncontrolling interest			12,255				16,840
Net income attributable to Inter Parfums, Inc.		$	41,048			$	54,068
Earnings per share:
Net income attributable to Inter Parfums, Inc. common shareholders:
Basic		$	1.28			$	1.69
Diluted		$	1.27			$	1.68
Weighted average number of shares outstanding:
Basic			32,041				32,018
Diluted			32,266				32,159
Dividends declared per share		$	0.75			$	0.625

 

See notes to consolidated financial statements.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 (In thousands)

(Unaudited)

 

		Three Months Ended March 31,
		2024				2023
Comprehensive income:
Net income		$	53,303			$	70,908
Other comprehensive income:
Net derivative instrument loss, net of tax			(956	)			(4,166	)
Transfer from OCI into earnings			64				1,709
Translation adjustments, net of tax			(14,582	)			13,489
Comprehensive income			37,829				81,940
Comprehensive income attributable to the noncontrolling interests:
Net income			12,255				16,840
Other comprehensive income:
Net derivative instrument loss, net of tax			(228	)			(206	)
Translation adjustments, net of tax			(5,017	)			3,622
Comprehensive income attributable to the noncontrolling interests			7,010				20,256
Comprehensive income attributable to Inter Parfums, Inc.		$	30,819			$	61,684

 

See notes to consolidated financial statements.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 (In thousands)

(Unaudited)

 

		Three months ended March 31,
		2024				2023
Common stock, beginning and end of period		$	32			$	32
			-				-
			32				32
Additional paid-in capital, beginning of period			98,565				90,186
Shares issued upon exercise of stock options			1,326				4,929
Share-based compensation			261				314
Transfer of subsidiary shares purchased			157				—
Additional paid-in capital, end of period			100,309				95,429
Retained earnings, beginning of period			693,848				620,095
Net income			41,048				54,068
Dividends			(24,032	)			(20,023	)
Share-based compensation			179				300
Retained earnings, end of period			711,043				654,440
Accumulated other comprehensive loss, beginning of period			(40,188	)			(56,056	)
Foreign currency translation adjustment, net of tax			(9,565	)			9,867
Transfer from other comprehensive income into earnings			64				1,709
Net derivative instrument loss, net of tax			(728	)			(3,960	)
Accumulated other comprehensive loss, end of period			(50,417	)			(48,440	)
Treasury stock, beginning of period			(52,864	)			(37,475	)
Shares repurchased			—				(5,580	)
Treasury stock, end of period			(52,864	)			(43,055	)
Noncontrolling interest, beginning of period			192,777				171,364
Net income			12,255				16,840
Foreign currency translation adjustment, net of tax			(5,017	)			3,622
Net derivative instrument loss, net of tax			(228	)			(206	)
Share-based compensation			154				54
Transfer of subsidiary shares purchased			(157	)			—
Dividends			—				(473	)
Noncontrolling interest, end of period			199,784				191,201
			892,170				788,146
			53,303				70.908
Total equity		$	907,887			$	849,607

 

See notes to consolidated financial statements.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

		Three months ended March 31,
		2024				2023
Cash flows from operating activities:
Net income		$	53,303			$	70,908
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization			6,018				4,115
Provision for doubtful accounts			(153	)			220
Noncash stock compensation			589				633
Share of income of equity investment			32				(41	)
Noncash lease expense			1,485				1,324
Deferred tax provision			(1,461	)			(1,188	)
Change in fair value of derivatives			(24	)			1,518
Changes in:
Accounts receivable			(50,436	)			(42,670	)
Inventories			(34,388	)			(29,688	)
Other assets			(5,245	)			(5,640	)
Operating lease liabilities			(1,468	)			(1,293	)
Accounts payable and accrued expenses			(27,736	)			(23,327	)
Income taxes, net			7,524				17,771
Net cash used in operating activities			(51,960	)			(7,358	)
Cash flows from investing activities:
Purchases of short-term investments			(59,619	)			(42,835	)
Proceeds from sale of short-term investments			74,905				107,045
Purchases of property, equipment and leasehold improvements			(1,059	)			(2,415	)
Payment for intangible assets acquired			(305	)			(151	)
Net cash provided by investing activities			13,922				61,644
Cash flows from financing activities:
Proceeds from loans payable, bank			4,000				—
Proceeds from issuance of long-term debt			—				17,989
Repayment of long-term debt			(9,425	)			(9,397	)
Proceeds from exercise of options			1,326				4,929
Dividends paid			(24,032	)			(20,023	)
Dividends paid to noncontrolling interest			—				(473	)
Purchase of treasury stock			—				(5,580	)
Net cash used in financing activities			(28,131	)			(12,555	)
Effect of exchange rate changes on cash			(1,317	)			2,611
Net (decrease) increase in cash and cash equivalents			(67,486	)			44,342
Cash and cash equivalents - beginning of period			88,462				104,713
Cash and cash equivalents - end of period		$	20,976			$	149,055
Supplemental disclosure of cash flow information:
Cash paid for:
Interest		$	1,127			$	1,563
Income taxes			10,479				4,816

 

See notes to consolidated financial statements.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

1.

Significant Accounting Policies:

 

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2023.

 

 

2.

Recent Agreements:

 

Abercrombie & Fitch

 

In 2023, we announced our agreement to distribute Abercrombie & Fitch’s number one men’s fragrance, Fierce, in selected markets. The first phase of the agreement, which became effective on September 1, 2023, covers Fierce distribution in certain major markets, including Europe, Mexico and Australia. The second phase, which activated in February 2024, covers distribution in additional markets in Western Europe and Latin America, and may include other flankers of the Fierce family of products.

 

Roberto Cavalli

 

In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in July 2023 and will last for 6.5 years. We began shipping Roberto Cavalli perfumes and fragrance related products in February 2024.

 

Lacoste

 

In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in January 2024 and will last for 15 years. We began shipping Lacoste fragrances in January 2024.

 

Dunhill

 

The Dunhill fragrance license expired on September 30, 2023 and was not renewed. The Company has a twelve-month sell-off period during which it will maintain the right to sell-off remaining Dunhill fragrance inventory, which is customary in the fragrance industry. All usable components have been converted to finished goods, and any remaining components will be destroyed.

 

Rochas Fashion

 

As a result of operational challenges faced by the Rochas Fashion business in prior years, we took a $2.4 million impairment charge and a $6.8 million impairment charge on our Rochas fashion trademark in the first quarter of 2021 and the fourth quarter of 2022, respectively. In 2023, the Rochas teams underwent a strategic shift to take over their own brand operations, exiting contracts with manufacturers and distributors to make this new structure operational beginning in 2024. An independent expert concluded that the valuation based on this new business model would not require additional impairments as of December 31, 2023. There have been no triggering events in the first quarter of 2024 to require additional impairment analysis.

 

Page 7 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

Land and Building Acquisition - Headquarters in Paris

 

In April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

 

The purchase price included the complete renovation of the site. As of March 31, 2024, $151 million (€139 million) of the purchase price, including approximately $3.1 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying consolidated balance sheet. The purchase price has been allocated approximately $61.9 million (€57 million) to land and $88.8 million (€82 million) to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. As of March 31, 2024, there was no cash held in escrow included in property, equipment and leasehold improvements on the accompanying consolidated balance sheet.

 

The acquisition was financed by a 10-year €120 million (approximately $129.7 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

 

 

3.

Recent Accounting Pronouncements:

 

There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

 

 

4.

Inventories:

 

Inventories consist of the following:

 

(In thousands)		March 31, 2024				December 31, 2023
Raw materials and component parts		$	178,678			$	158,733
Finished goods			221,531				213,126
		$	400,209			$	371,859

 

Page 8 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

5.

Fair Value Measurement:

 

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

 

						Fair Value Measurements at March 31, 2024
		Total				Quoted Prices in Active Markets for Identical Assets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Unobservable Inputs (Level 3)
Assets:
Short-term investments		$	76,078			$	10,379			$	65,699			$	—
Interest rate swaps			4,096				—				4,096				—
Foreign currency forward exchange contracts not accounted for using hedge accounting			395				—				395				—
Foreign currency forward exchange contracts accounted for using hedge accounting			305			$	—				305				—
		$	80,874			$	10,379			$	70,495			$	—

 

						Fair Value Measurements at December 31, 2023
		Total				Quoted Prices in Active Markets for Identical Assets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Unobservable Inputs (Level 3)
Assets:
Short-term investments		$	94,304			$	12,868			$	80,614			$	822
Interest rate swaps			3,909				—				3,909				—
Foreign currency forward exchange contracts not accounted for using hedge accounting			359				—				359				—
Foreign currency forward exchange contracts accounted for using hedge accounting			1,533				—				1,533				—
		$	100,105			$	12,868			$	86,415			$	822

 

The carrying amount of cash and cash equivalents, short-term investments including money market funds and marketable equity securities, accounts receivable, other receivables, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

 

 

Page 9 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

  

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps is the discounted net present value of the swaps using third party quotes from financial institutions.

 

 

6.

Derivative Financial Instruments:

 

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings. 

 

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $54.1 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

 

In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $129.7 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

 

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying consolidated statements of income. Such gains and losses were immaterial for both the three months ended March 31, 2024 and 2023.

 

All derivative instruments are reported as either assets or liabilities on the consolidated balance sheet measured at fair value. The valuation of interest rate swaps is included in long-term debt on the accompanying consolidated balance sheets. The valuation of foreign currency forward exchange contracts at March 31, 2024, resulted in a net asset and is included in other current assets on the accompanying consolidated balance sheet.

 

Page 10 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

At March 31, 2024, the Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $78.0 million and GB £4.7 million which all have maturities of less than one year.

 

 

7.

Leases:

 

The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

 

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

 

As of March 31, 2024, the weighted average remaining lease term was 4.8 years and the weighted average discount rate used to determine the operating lease liability was 3%. Rental expense related to operating leases was $1.6 million and $1.4 million for the three months ended March 31, 2024 and 2023, respectively. Operating lease payments included in operating cash flows totaled $1.5 million and $1.3 million for the three months ended March 31, 2024 and 2023, respectively. There were $0.2 million of noncash additions to operating lease assets for the three months ended March 31, 2024 and no noncash additions to operating lease assets for the three months ended March 31, 2023.

 

8.

Share-Based Payments:

 

The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the three months ended March 31, 2024 and 2023 aggregated $0.04 million and $0.09 million, respectively. Compensation cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

 

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:

 

		Number of Shares				Weighted Average Grant-Date Fair Value
Nonvested options – beginning of period			122,100			$	24.47
Nonvested options granted			—				—
Nonvested options vested or forfeited			(3,140	)		$	11.86
Nonvested options – end of period			118,960			$	24.80

  

Page 11 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

Share-based payment expense decreased income before income taxes by $0.59 million and $0.63 million for the three months ended March 31, 2024 and 2023, respectively, and decreased income attributable to Inter Parfums, Inc. by $0.39 million and $0.43 million for the three months ended March 31, 2024 and 2023, respectively.

 

The following table summarizes stock option information as of March 31, 2024:

 

		Shares				Weighted Average Exercise Price
Outstanding at January 1, 2024			308,970			$	86.52
Options forfeited			(140	)			73.09
Options exercised			(18,980	)			69.87
Outstanding at March 31, 2024			289,850			$	87.62
Options exercisable			170,890			$	70.60
Options available for future grants			537,505

 

As of March 31, 2024, the weighted average remaining contractual life of options outstanding is 2.69 years (0.5 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $15.7 million and $11.9 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.7 million.

 

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:

 

(In thousands)		March 31, 2024				March 31, 2023
Cash proceeds from stock options exercised		$	1,326			$	4,929
Tax benefits			220				780
Intrinsic value of stock options exercised			1,375				5,403

 

There were no options granted during the three months ended March 31, 2024 and March 31, 2023.

 

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors maintain its current payout ratio as a percentage of earnings.

 

In March 2022, Interparfums SA, our 72% owned French Subsidiary, approved a plan to grant an aggregate of 88,400 shares of its stock to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025.

 

The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of 93,612 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.2 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.

 

Page 12 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

In order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of March 31, 2024 the Company acquired 87,609 shares at an aggregate cost of $4.1 million.

 

All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

 

9.

Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

 

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

 

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

 

		Three months ended
(In thousands)		March 31,
		2024				2023
Numerator:
Net income attributable to Inter Parfums, Inc.		$	41,048			$	54,068
Denominator:
Weighted average shares			32,041				32,018
Effect of dilutive securities:
Stock options			225				141
Denominator for diluted earnings per share			32,266				32,159
Earnings per share:
Net income attributable to Inter
Parfums, Inc. common shareholders:
Basic		$	1.28			$	1.69
Diluted			1.27				1.68

 

Not included in the above computations are the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.05 million shares of common stock for the three months ended March 31, 2024. There were no antidilutive potential common shares outstanding for the three months ended March 31, 2023.

 

Page 13 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Notes to Consolidated Financial Statements

 

10.

Segment and Geographic Areas:

 

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European based operations and United States based operations primarily represent the sale of prestige brand name fragrances.

 

Information on our operations by segments is as follows:

 

(In thousands)		Three months ended March 31,
		2024				2023
Net sales:
United States		$	95,768			$	81,454
Europe			230,957				230,269
Eliminations of intercompany sales			(2,762	)			—
		$	323,963			$	311,723
Net income attributable to Inter Parfums, Inc.:
United States		$	9,527			$	10,343
Europe			32,685				43,725
Eliminations			(1,164	)			—
		$	41,048			$	54,068

 

		March 31,				December 31,
		2024				2023
Total Assets:
United States		$	337,876			$	344,341
Europe			1,069,258				1,066,684
Eliminations			(57,958	)			(41,696	)
		$	1,349,176			$	1,369,329

 

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 2:

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward Looking Information

 

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and “would” or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Inter Parfums’ annual report on Form 10-K for the fiscal year ended December 31, 2023, and the reports Inter Parfums files from time to time with the Securities and Exchange Commission (“SEC”). Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

 

Overview

 

We operate in the fragrance business, and manufacture, market and distribute a wide array of prestige fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European based operations through our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the Euronext.

 

We produce and distribute fragrance products through our European based operations primarily under license agreements with brand owners, and European based fragrance product sales represented approximately 70% and 74% of net sales for the three months ended March 31, 2024 and 2023, respectively. We have built a portfolio of prestige brands, which include Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world. Our exclusive and worldwide license for the production and distribution of Lacoste brand perfumes and cosmetics became effective in January 2024.

 

Through our United States based operations, we also market fragrance and fragrance related products. United States based operations represented 30% and 26% of net sales for the three months ended March 31, 2024 and 2023, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of the Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta and Roberto Cavalli brands.

 

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Coach, Jimmy Choo, GUESS, Donna Karan/DKNY and Ferragamo brand names.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

 

		Three Months Ended March 31,
		2024				2023
Montblanc			18	%			20	%
Coach			15	%			15	%
Jimmy Choo			15	%			20	%
GUESS			10	%			9	%
Donna Karan/DKNY			6	%			4	%
Ferragamo			3	%			4	%

 

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France, the United States, and Italy.

 

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, through new licenses, or other arrangements or outright acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling, as well as phasing out underperforming products, so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. The introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

 

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received and stored directly at our third-party fillers or received at one of our distribution centers. For those components received at one of our distribution centers, based upon production needs, the components are subsequently sent to one of several third party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

 

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share. 

 

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, earnings are positively affected by a strong dollar, because greater than 50% of net sales of our European based operations are denominated in U.S. dollars, while almost all costs of our European based operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Recent Important Events

 

Please see our discussion of Recent Important Events, which is incorporated by reference to Note 2 to the Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024.

 

Discussion of Critical Accounting Policies

 

Information regarding our critical accounting policies can be found in our 2023 Annual Report on Form 10-K filed with the SEC.

 

Results of Operations

 

Three Months Ended March 31, 2024 as Compared to the Three Months Ended March 31, 2023

 

Net Sales:

 

		Three months ended March 31,
(in millions)		2024				2023				% Change
European based product sales		$	231.0			$	230.3				0.3	%
United States based product sales			95.8				81.4				17.6	%
Eliminations			(2.8	)			—				—
		$	324.0			$	311.7				3.9	%

 

Net sales for the three months ended March 31, 2024 increased 4% from the three months ended March 31, 2023. At comparable foreign currency exchange rates, net sales increased 3% from the first quarter of 2023. The average dollar/euro exchange rate for the current first quarter was 1.09 compared to 1.07 in the first quarter of 2023.

 

The current first quarter saw modest sales growth, as compared to the corresponding period of the prior year, largely due to the exceptional performance of both European and United States based operations in 2023.

 

For European based operations, Coach grew sales by 5% while Montblanc and Jimmy Choo saw decreases in sales of 5% and 23%, respectively, as compared to the corresponding period of the prior year. This was largely driven by the substantial increases in sales of Montblanc and Jimmy Choo in the first quarter of 2023 of 28% and 63%, respectively, as compared to the first quarter of 2022. During the first quarter of 2024, we began selling the Lacoste brand, which added $20 million in sales.

 

Sales by our United States based operations had a strong start growing 18% off a high 2023 base when first quarter sales had expanded 19%. This increase was driven by the addition and extension of Roberto Cavalli to our portfolio and double-digit growth for GUESS and Donna Karan/DKNY, following successful brand extensions and continued brand expansion.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

During the first quarter of 2024, we debuted Montblanc Legend Blue, which contributed to the continued brand strength as our largest brand. Additionally, during the first quarter of 2024, we debuted the Donna Karan Cashmere Collection, which helped the brand to see double digit growth. Many of our mid-sized brands, including Van Cleef & Arpels, Kate Spade and MCM, also achieved double digit sales gains. Additionally, we introduced brand extensions within established lines for Abercrombie & Fitch and Anna Sui.

 

While our first quarter grew more moderately than the first quarter of 2023, we are confident in our future as we look forward to executing our plans for the remainder of 2024. Our brands are in high demand in a robust environment for the fragrance industry, and we have many exciting developments planned for the Company. We have a large number of brand extensions across many of our brands launching throughout the year, including a new flanker for the I Want Choo line planned for the second quarter of 2024, plus the first launch of an Interparfums developed blockbuster fragrance for Lacoste, later in the year. Additionally, there is a new flanker for Roberto Cavalli Signature and a new DKNY blockbuster fragrance planned for the second half of 2024. In sum, 2024 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds.

 

Net Sales to Customers by Region		Three months ended March 31,
(In millions)		2024				2023
North America		$	108.1			$	111.2
Western Europe			85.1				77.2
Asia/Pacific			51.8				46.0
Central and South America			34.4				26.2
Middle East and Africa			27.1				28.6
Eastern Europe			17.5				22.5
		$	324.0			$	311.7

 

First quarter sales in Western Europe rose 10%, followed by Asia/Pacific and Central and South America where comparable quarter sales in both regions increased 13% and 31%, respectively. Our sales in North America decreased slightly by 3% as the first quarter of 2023 saw large increases due to the new product launches previously discussed. While our sales in North America saw minimal decreases, the region is still strong and is our largest region across the Company. Additionally, our travel retail business is continuing to show signs of renewed life. Eastern Europe was adversely impacted by sourcing constraints in certain countries which resulted in sales shifting from the first quarter into the second quarter of 2024.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Gross Profit margin		Three months ended March 31,
(in millions)		2024				2023
European based operations
Net sales		$	231.0			$	230.3
Cost of sales			83.2				74.3
Gross margin		$	147.8			$	156.0
Gross margin as a % of net sales			64.0	%			67.8	%
United States based operations
Net sales		$	95.8			$	81.4
Cost of sales			39.6				34.5
Gross margin		$	56.2			$	46.9
Gross margin as a % of net sales			58.7	%			57.6	%

 

The Company’s gross profit margin as a percentage of net sales was 62.5% for the three months ended March 31, 2024 as compared to 65.1% for the three months ended March 31, 2023. The decrease was driven by unfavorable segment, geographic and channel mix, as well as increased trade spending to support our business in the absence of significant innovation. We also incurred slight cost inflation on the raw materials we purchased in 2023. We expect many of these adverse impacts to be non-recurring and should normalize over the balance of the year.

 

For European based operations, gross profit margin as a percentage of net sales was 64.0% and 67.8% in the first quarters of 2024 and 2023, respectively. European based operations were impacted by geographic and channel mix, as well as increased trade spending to support the business in the absence of significant new innovation in the first quarter of 2024. Additionally, cost inflation impacts on raw materials purchased in Europe were more significant as energy costs rose in the region. We expect many of these adverse impacts to be non-recurring and should normalize over the balance of the year.

 

For United States based operations, gross profit margin as a percentage of net sales was 58.7% and 57.6% in the first quarters of 2024 and 2023, respectively. Similar to 2023, gross margins continued to expand behind strong cost containment efforts as well as a more favorable brand and channel mix, as a higher portion of our sales are being sold directly to retailers as opposed to third-party distributors. Additionally, the significant increase in sales in the first quarter of 2024 allowed us to continue to absorb fixed expenses such as depreciation and point of sale expenses, as compared to the corresponding period of the prior year.

 

Generally, we do not bill customers for shipping and handling costs, and such costs, which aggregated $2.5 million and $3.9 million for the three months ended March 31, 2024 and 2023, respectively, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to other companies, which may include these expenses as a component of cost of goods sold. The improvement in shipping and handling costs in the first quarter of 2024 as compared to corresponding period in 2023 was a direct benefit of lower transportation costs seen globally.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Selling, general and administrative expenses		Three months ended March 31,
(In millions)		2024				2023
European based operations
Selling, general and administrative expenses		$	90.4			$	77.3
Selling, general and administrative expenses as a percent of net sales			39.1	%			33.6	%
United States based operations
Selling, general and administrative expenses		$	44.0			$	35.4
Selling, general and administrative expenses as a percent of net sales			46.0	%			43.5	%

 

The Company’s selling, general and administrative expenses as a percentage of net sales was 41.5% for the three months ended March 31, 2024 as compared to 36.1% for the three months ended March 31, 2023. The increase was largely driven by increased spending on promotional and advertising activities in the first quarter of 2024 as compared to the prior year period. Additionally, starting in 2024, the Company began to amortize the cost of the Lacoste license which represented $1.6 million during the first quarter. These costs will be incurred quarterly over the remaining life of the license.

 

For European based operations, selling, general and administrative expenses increased 16.9% for the three months ended March 31, 2024, as compared to the corresponding period of the prior year, and represented 39.1% and 33.6% of net sales in the 2024 and 2023 periods, respectively. As discussed above, this increase is driven by increased promotion and advertising spending as well as the impact of the amortization of the Lacoste license. For United States based operations, selling, general and administrative expenses increased 24.5% for the three months ended March 31, 2024, as compared to the corresponding period of the prior year, and represented 46.0% and 43.5% of net sales in the 2024 and 2023 periods, respectively. As discussed in more detail below, these fluctuations are primarily from variations in promotion and advertising expenditures.

 

Promotion and advertising included in selling, general and administrative expenses aggregated $48.3 million and $35.2 million in the first quarters of 2024 and 2023, respectively, and represented 14.9% and 11.3% of net sales in the 2024 and 2023 periods, respectively. Promotion and advertising are integral parts of our industry, and we continue to invest heavily to support new product launches and to build brand awareness. We believe that our promotion and advertising efforts have a beneficial effect on sales. Historically, the Company incurred the majority of our promotional and advertising expenditures in the second half of the year. Beginning in 2024, the Company implemented a strategy to increase spending in the first half of the year to better support and drive business growth throughout the year. Additionally, as the first quarter of 2024 saw a lighter innovation program than prior years, the Company focused on increasing promotional and advertising spending to support the continued success of our existing brands and to support the initial launch of our new brands, Lacoste and Roberto Cavalli. We also continue to develop and implement omnichannel concepts and compelling content to deliver an integrated consumer experience. Long term, we continue to anticipate that on a full year basis, promotion and advertising expenditures will aggregate approximately 21% of net sales.

 

Royalty expense included in selling, general and administrative expenses aggregated $27.2 million for the three months ended March 31, 2024, as compared to $24.1 million for the corresponding periods of the prior year. Royalty expense represented 8.4% and 7.7% of net sales for the three months ended March 31, 2024 and 2023, respectively. This increase was primarily driven by unfavorable brand mix.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Income from Operations

 

As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, our operating margins aggregated 21.0% and 29.0% for the three months ended March 31, 2024 and 2023, respectively.

 

Other Income and Expense

 

Interest expense is primarily related to the financing of brand and licensing acquisitions. In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a $54.1 million (€50 million) four-year loan agreement. The loan agreement bears interest at EURIBOR-1 month rates plus a margin of 0.825%. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. Additionally, in April 2021, we completed the acquisition of the headquarters of Interparfums SA. The acquisition was financed by a 10-year approximately $129.7 million (€120 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately $86.5 million (€80 million) of the variable rate debt was swapped for fixed interest rate debt with a maximum interest rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%. Long-term debt including current maturities aggregated $145.0 million and $157.5 million as of March 31, 2024 and December 31, 2023, respectively.

 

We enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Greater than 50% of net sales of our European based operations are denominated in U.S. dollars. Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying consolidated income statements. Such gains and losses were immaterial in the three months ended March 31, 2024 and 2023.

 

Interest and investment income represents interest earned on cash and cash equivalents and short-term investments. As of March 31, 2024, short-term investments include approximately $10.4 million of marketable equity securities of other companies in the luxury goods sector. In the first quarter of 2023, the Company sold marketable securities which generated a gain of $3.1 million. The Company purchased additional marketable securities throughout 2023 and in the first quarter of 2024, which generated unrealized gain of $0.9 million during the first quarter of 2024.

 

Income Taxes

 

Our consolidated effective tax rate was 23.9% and 23.4% for the three months ended March 31, 2024 and 2023, respectively. The effective tax rate for European based operations was 25% for both the three months ended March 31, 2024 and 2023. The effective tax rate for United States based operations was 17.7% for the three months ended March 31, 2024, as compared to 12.7% for the corresponding period of the prior year. Our effective tax rate differs from the 21% statutory rate due to benefits received from the exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income, slightly offset by state and local taxes. Other than as discussed above, we did not experience any significant changes in tax rates, and none were expected in jurisdictions where we operate.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Net Income

 

		Three Months Ended     March 31,
		2024				2023
		(In thousands)
Net income attributable to European based operations		$	44,940			$	60,565
Net income attributable to United States based operations			9,527				10,343
Eliminations			(1,164	)			—
Net income			53,303				70,908
Less: Net income attributable to the noncontrolling interest			12,255				16,840
Net income attributable to Inter Parfums, Inc.		$	41,048			$	54,068

 

Net income attributable to Inter Parfums, Inc. was $41.0 million for the three months ended March 31, 2024 as compared to $54.1 million for the corresponding period of the prior year.

 

Net income attributable to European based operations was $44.9 million and $60.6 million for the three months ended March 31, 2024 and 2023, respectively, while net income attributable to United States based operations was $9.5 million and $10.3 million for the three months ended March 31, 2024 and 2023, respectively. The significant fluctuations in net income for both European based operations and United States based operations are directly related to the previous discussions pertaining to changes in sales, gross margin, and selling, general and administrative expenses.

 

The noncontrolling interest arises from our 72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as 28% of Interparfums SA shares trade on the Euronext. Net income attributable to the noncontrolling interest is directly related to the profitability of our European based operations and aggregated 27.3% and 27.8% of European based operations net income for the three months ended March 31, 2024 and 2023, respectively. Net profit margins attributable to Inter Parfums, Inc. as of March 31, 2024 and 2023 aggregated 12.7% and 17.3%, respectively.

 

Liquidity and Capital Resources

 

Our conservative financial tradition has enabled us to amass significant cash balances. As of March 31, 2024, we had $97 million in cash, cash equivalents and short-term investments, most of which are held in euro by our European based operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments.

 

As of March 31, 2024, working capital aggregated $530 million and we had a working capital ratio of 2.8 to 1. Approximately 79% of the Company’s total assets are held by European based operations, and approximately $248 million of trademarks, licenses and other intangible assets are also held by European based operations.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

The Company is party to a number of licenses and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039. In connection with most of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. See Item 8. Financial Statements and Supplementary Data – Note 12 – Commitments in our 2023 annual report on Form 10-K, which is incorporated by reference herein. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2023, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

 

The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. In July 2023, we entered into a global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Roberto Cavalli brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. This license took effect in July 2023, and we began shipping products in February 2024.

 

In December 2022, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance-related products under the Lacoste brand. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. This license took effect and products started to ship in January 2024.

 

Cash used in operating activities aggregated $52.0 million and $7.4 million for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024, working capital items used $111.7 million in cash from operating activities, as compared to $84.8 million in the 2023 period. Although from a cash flow perspective, accounts receivable is up 20% from year end 2023, the balance is reasonable based on first quarter 2024 record sales levels and seasonality of the business. Although day’s sales outstanding was 73 days, up from 71 days in the corresponding period of the prior year, we are still seeing strong collection activity and do not anticipate any issues with collections of accounts receivable. From a cash flow perspective, inventory levels as of March 31, 2024 increased 9% from year end 2023 in support of our overall sales growth. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold.

 

Cash flows provided by investing activities in 2024 reflect purchases and sales of short-term investments. These investments consist of certificates of deposit with maturities greater than three months, marketable equity securities and other contracts. At March 31, 2024, approximately $2.0 million of certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.

 

Our business is not capital intensive as we do not own any manufacturing facilities. On a full year basis, we typically spend approximately $5.0 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Cash flows used in financing activities in the first quarter of 2024 reflect issuances and repayments of debt and payment of dividends to stockholders.

 

Our short-term financing requirements are expected to be met by available cash on hand at March 31, 2024, and by short-term credit lines provided by domestic and foreign banks. The principal credit facilities for 2024 consist of a $25.0 million unsecured revolving line of credit provided by a domestic commercial bank and approximately $8 million in credit lines provided by a consortium of international financial institutions. There was $8.3 million of short-term borrowings outstanding pursuant to these facilities as of March 31, 2024 and $18.0 million outstanding as of March 31, 2023.

 

In February 2023, the Board of Directors authorized an annual dividend of $2.50 per share. In February 2024, the Board of Directors further increased the annual dividend to $3.00 per share. The next quarterly cash dividend of $0.75 per share is payable on June 28, 2024, to shareholders of record on June 14, 2024.

 

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

 

Inflation rates in the U.S. and foreign countries in which we operate did impact operating results for the three months ended March 31, 2024, as they resulted in slightly higher costs of inventory and were not fully offset by price increases we passed onto our respective customers or operating efficiencies.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 3:

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

General

 

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

 

Foreign Exchange Risk Management

 

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

 

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

 

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

 

At March 31, 2024, we had foreign currency contracts in the form of forward exchange contracts of approximately U.S. $78.0 million and GB £4.7 million with maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

 

Interest Rate Risk Management

 

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 4.

CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our Company’s disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Part II. Other Information

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

Item (c).

 

In December 2022, our Board of Directors authorized a share repurchase program for our outstanding common stock. During 2023, the Company repurchased 116,860 shares at a cost of $15.4 million. These shares are classified as treasury shares on the accompanying consolidated balance sheet. In February 2024, our Board of Directors authorized the Company to continue repurchasing up to 130,000 shares throughout 2024.

 

Inter Parfums, Inc. Purchase of Common Stock
Period	Total Number of Shares Purchased	Average price paid per share	Total number of shares purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs
January 1-31	0	n/a	0	130,000 shares
February 1-29	0	n/a	0	130,000 shares
March 1-31	0	n/a	0	130,000 shares
Total	0	n/a	0	130,000 shares

 

Item 5. Other Information

 

Item (c). During the first quarter of 2024, no director or officer has adopted or terminated either any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as such terms are defined in the applicable regulation.

 

Items 1. Legal Proceedings, 1A. Risk Factors, 3. Defaults Upon Senior Securities and 4. Mine Safety Disclosures, are omitted as they are either not applicable or have been included in Part I.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Item 6. Exhibits.

 

The following documents are filed herewith:

 

Exhibit No.	Description	Page Number
31.1	Certifications required by Rule 13a-14(a) of Chief Executive Officer	29
31.2	Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer	30
32.1	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer	31
32.2	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer	32
101	Interactive data files

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 7th day of May 2024.

 

		INTER PARFUMS, INC.
	By:	/s/ Michel Atwood
		Chief Financial Officer

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Jean Madar, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: May 7, 2024

 

/s/ Jean Madar
Jean Madar,
Chief Executive Officer

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 31.2

 

I, Michel Atwood, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Inter Parfums, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based upon such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: May 7, 2024

 

/s/ Michel Atwood
Michel Atwood
Chief Financial Officer and
Principal Accounting Officer

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 32.1

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended March 31, 2024, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: May 7, 2024		By:	/s/ Jean Madar
			Jean Madar,
			Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

INTER PARFUMS, INC. AND SUBSIDIARIES

 

Exhibit 32.2

 

CERTIFICATION

 

The undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Inter Parfums, Inc., that the Quarterly Report of Inter Parfums, Inc. on Form 10-Q for the period ended March 31, 2024, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of Inter Parfums, Inc.

 

Date: May 7, 2024		By:	/s/ Michel Atwood
			Michel Atwood
			Chief Financial Officer and
			Principal Accounting Officer

 

A signed original of this written statement required by Section 906 has been provided to Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

v3.24.1.u1

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 07, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	0-16469
Entity Registrant Name	INTER PARFUMS, INC.
Entity Central Index Key	0000822663
Entity Tax Identification Number	13-3275609
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	551 Fifth Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10176
City Area Code	(212)
Local Phone Number	983-2640
Title of 12(b) Security	Common Stock, $.001 par value per share
Trading Symbol	IPAR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		32,023,640

v3.24.1.u1

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 20,976	$ 88,462
Short-term investments	76,078	94,304
Accounts receivable, net	293,075	247,240
Inventories	400,209	371,859
Receivables, other	5,581	7,012
Other current assets	34,258	29,458
Income taxes receivable	2,490	691
Total current assets	832,667	839,026
Property, equipment and leasehold improvements, net	164,165	169,222
Right-of-use assets, net	26,980	28,613
Trademarks, licenses and other intangible assets, net	288,117	296,356
Deferred tax assets	15,726	14,545
Other assets	21,521	21,567
Total assets	1,349,176	1,369,329
Current liabilities:
Loans payable - banks	8,324	4,420
Current portion of long-term debt	29,027	29,587
Current portion of lease liabilities	5,928	5,951
Accounts payable – trade	106,219	97,409
Accrued expenses	135,660	178,880
Income taxes payable	17,300	8,498
Total current liabilities	302,458	324,745
Long–term debt, less current portion	115,926	127,897
Lease liabilities, less current portion	22,905	24,517
Equity:
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,023,640 and 32,004,660 shares at March 31, 2024 and December 31, 2023, respectively	32	32
Additional paid-in capital	100,309	98,565
Retained earnings	711,043	693,848
Accumulated other comprehensive loss	(50,417)	(40,188)
Treasury stock, at cost, 9,981,665 and 9,981,665 shares at March 31, 2024 and December 31, 2023, respectively	(52,864)	(52,864)
Total Inter Parfums, Inc. shareholders’ equity	708,103	699,393
Noncontrolling interest	199,784	192,777
Total equity	907,887	892,170
Total liabilities and equity	$ 1,349,176	$ 1,369,329

v3.24.1.u1

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common stock, authorized	100,000,000	100,000,000
Common stock, outstanding	32,023,640	32,004,660
Treasury stock, shares	9,981,665	9,981,665

v3.24.1.u1

CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 323,963	$ 311,723
Cost of sales	121,578	108,766
Gross margin	202,385	202,957
Selling, general and administrative expenses	134,412	112,678
Income from operations	67,973	90,279
Other expenses (income):
Interest expense	1,807	2,357
(Gain) loss on foreign currency	(905)	759
Interest and investment income	(3,020)	(5,382)
Other expense (income)	38	(41)
Nonoperating Income (Expense)	(2,080)	(2,307)
Income before income taxes	70,053	92,586
Income taxes	16,750	21,678
Net income	53,303	70,908
Less:  Net income attributable to the noncontrolling interest	12,255	16,840
Net income attributable to Inter Parfums, Inc.	$ 41,048	$ 54,068
Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$ 1.28	$ 1.69
Diluted	$ 1.27	$ 1.68
Weighted average number of shares outstanding:
Basic	32,041	32,018
Diluted	32,266	32,159
Dividends declared per share	$ 0.75	$ 0.625

v3.24.1.u1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Comprehensive income:
Net income	$ 53,303	$ 70,908
Other comprehensive income:
Net derivative instrument loss, net of tax	(956)	(4,166)
Transfer from OCI into earnings	64	1,709
Translation adjustments, net of tax	(14,582)	13,489
Comprehensive income	37,829	81,940
Comprehensive income attributable to the noncontrolling interests:
Net income	12,255	16,840
Net derivative instrument loss, net of tax	(228)	(206)
Translation adjustments, net of tax	(5,017)	3,622
Comprehensive income attributable to the noncontrolling interests	7,010	20,256
Comprehensive income attributable to Inter Parfums, Inc.	$ 30,819	$ 61,684

v3.24.1.u1

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Beginning Balance at Dec. 31, 2022	$ 32	$ 90,186	$ 620,095	$ (56,056)	$ (37,475)	$ 171,364	$ 788,146
Shares issued upon exercise of stock options	(0)	4,929
Share-based compensation		314	300			54
Transfer of subsidiary shares purchased
Net income			54,068			16,840	70,908
Dividends			(20,023)			(473)
Foreign currency translation adjustment, net of tax				9,867		3,622
Transfer from other comprehensive income into earnings				1,709
Net derivative instrument income (loss), net of tax				(3,960)		(206)
Shares repurchased					(5,580)
Ending Balance at Mar. 31, 2023	32	95,429	654,440	(48,440)	(43,055)	191,201	849,607
Beginning Balance at Dec. 31, 2023	32	98,565	693,848	(40,188)	(52,864)	192,777	892,170
Shares issued upon exercise of stock options		1,326
Share-based compensation		261	179			154
Transfer of subsidiary shares purchased		157				(157)
Net income			41,048			12,255	53,303
Dividends			(24,032)
Foreign currency translation adjustment, net of tax				(9,565)		(5,017)
Transfer from other comprehensive income into earnings				64
Net derivative instrument income (loss), net of tax				(728)		(228)
Shares repurchased
Ending Balance at Mar. 31, 2024	$ 32	$ 100,309	$ 711,043	$ (50,417)	$ (52,864)	$ 199,784	$ 907,887

v3.24.1.u1

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 53,303	$ 70,908
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	6,018	4,115
Provision for doubtful accounts	(153)	220
Noncash stock compensation	589	633
Share of income of equity investment	32	(41)
Noncash lease expense	1,485	1,324
Deferred tax provision	(1,461)	(1,188)
Change in fair value of derivatives	(24)	1,518
Changes in:
Accounts receivable	(50,436)	(42,670)
Inventories	(34,388)	(29,688)
Other assets	(5,245)	(5,640)
Operating lease liabilities	(1,468)	(1,293)
Accounts payable and accrued expenses	(27,736)	(23,327)
Income taxes, net	7,524	17,771
Net cash used in operating activities	(51,960)	(7,358)
Cash flows from investing activities:
Purchases of short-term investments	(59,619)	(42,835)
Proceeds from sale of short-term investments	74,905	107,045
Purchases of property, equipment and leasehold improvements	(1,059)	(2,415)
Payment for intangible assets acquired	(305)	(151)
Net cash provided by investing activities	13,922	61,644
Cash flows from financing activities:
Proceeds from loans payable, bank	4,000
Proceeds from issuance of long-term debt		17,989
Repayment of long-term debt	(9,425)	(9,397)
Proceeds from exercise of options	1,326	4,929
Dividends paid	(24,032)	(20,023)
Dividends paid to noncontrolling interest		(473)
Purchase of treasury stock		(5,580)
Net cash used in financing activities	(28,131)	(12,555)
Effect of exchange rate changes on cash	(1,317)	2,611
Net (decrease) increase in cash and cash equivalents	(67,486)	44,342
Cash and cash equivalents - beginning of period	88,462	104,713
Cash and cash equivalents - end of period	20,976	149,055
Cash paid for:
Interest	1,127	1,563
Income taxes	$ 10,479	$ 4,816

v3.24.1.u1

Significant Accounting Policies:	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Significant Accounting Policies:	1. Significant Accounting Policies:   The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, 2023.

v3.24.1.u1

Recent Agreements:	3 Months Ended
	Mar. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Recent Agreements:	2. Recent Agreements:   Abercrombie & Fitch   In 2023, we announced our agreement to distribute Abercrombie & Fitch’s number one men’s fragrance, Fierce, in selected markets. The first phase of the agreement, which became effective on September 1, 2023, covers Fierce distribution in certain major markets, including Europe, Mexico and Australia. The second phase, which activated in February 2024, covers distribution in additional markets in Western Europe and Latin America, and may include other flankers of the Fierce family of products.   Roberto Cavalli   In July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in July 2023 and will last for 6.5 years. We began shipping Roberto Cavalli perfumes and fragrance related products in February 2024.   Lacoste   In December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. The license became effective in January 2024 and will last for 15 years. We began shipping Lacoste fragrances in January 2024.   Dunhill   The Dunhill fragrance license expired on September 30, 2023 and was not renewed. The Company has a twelve-month sell-off period during which it will maintain the right to sell-off remaining Dunhill fragrance inventory, which is customary in the fragrance industry. All usable components have been converted to finished goods, and any remaining components will be destroyed.   Rochas Fashion   As a result of operational challenges faced by the Rochas Fashion business in prior years, we took a $2.4 million impairment charge and a $6.8 million impairment charge on our Rochas fashion trademark in the first quarter of 2021 and the fourth quarter of 2022, respectively. In 2023, the Rochas teams underwent a strategic shift to take over their own brand operations, exiting contracts with manufacturers and distributors to make this new structure operational beginning in 2024. An independent expert concluded that the valuation based on this new business model would not require additional impairments as of December 31, 2023. There have been no triggering events in the first quarter of 2024 to require additional impairment analysis.   Land and Building Acquisition - Headquarters in Paris   In April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.   The purchase price included the complete renovation of the site. As of March 31, 2024, $151 million (€139 million) of the purchase price, including approximately $3.1 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying consolidated balance sheet. The purchase price has been allocated approximately $61.9 million (€57 million) to land and $88.8 million (€82 million) to the building. The building, which was delivered on February 28, 2022, includes the building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that will be depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on the useful lives of its components. As of March 31, 2024, there was no cash held in escrow included in property, equipment and leasehold improvements on the accompanying consolidated balance sheet.   The acquisition was financed by a 10-year €120 million (approximately $129.7 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

v3.24.1.u1

Recent Accounting Pronouncements:	3 Months Ended
	Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements:	3. Recent Accounting Pronouncements:   There are no recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

v3.24.1.u1

Inventories:	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories:	4. Inventories:   Inventories consist of the following:   (In thousands)   March 31, 2024     December 31, 2023   Raw materials and component parts   $ 178,678     $ 158,733   Finished goods     221,531       213,126                         $ 400,209     $ 371,859

v3.24.1.u1

Fair Value Measurement:	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurement:	5. Fair Value Measurement:   The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.                                                 Fair Value Measurements at March 31, 2024       Total     Quoted Prices in Active Markets for Identical Assets (Level 1)     Significant Other Observable Inputs (Level 2)     Significant Unobservable Inputs (Level 3)   Assets:                         Short-term investments   $ 76,078     $ 10,379     $ 65,699     $ —   Interest rate swaps     4,096       —       4,096       —   Foreign currency forward exchange contracts not accounted for using hedge accounting     395       —       395       —   Foreign currency forward exchange contracts accounted for using hedge accounting     305     $ —     305       —                                         $ 80,874     $ 10,379     $ 70,495     $ —                                                   Fair Value Measurements at December 31, 2023       Total     Quoted Prices in Active Markets for Identical Assets (Level 1)     Significant Other Observable Inputs (Level 2)     Significant Unobservable Inputs (Level 3)   Assets:                         Short-term investments   $ 94,304     $ 12,868     $ 80,614     $ 822   Interest rate swaps     3,909       —       3,909       —   Foreign currency forward exchange contracts not accounted for using hedge accounting     359       —       359       —   Foreign currency forward exchange contracts accounted for using hedge accounting     1,533       —       1,533       —                                         $ 100,105     $ 12,868     $ 86,415     $ 822     The carrying amount of cash and cash equivalents, short-term investments including money market funds and marketable equity securities, accounts receivable, other receivables, accounts payable and accrued expenses approximate fair value due to the short terms to maturity of these instruments. The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.      Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps is the discounted net present value of the swaps using third party quotes from financial institutions.

v3.24.1.u1

Derivative Financial Instruments:	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments:	6. Derivative Financial Instruments:   The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.    In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $54.1 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.   In connection with the April 2021 acquisition of the office building complex in Paris, €120 million (approximately $129.7 million) of the purchase price was financed through a 10-year term loan. The Company entered into interest rate swap contracts related to €80 million of the loan, effectively exchanging the variable interest rate to a fixed rate of approximately 1.1%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.   Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income (loss) and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying consolidated statements of income. Such gains and losses were immaterial for both the three months ended March 31, 2024 and 2023.   All derivative instruments are reported as either assets or liabilities on the consolidated balance sheet measured at fair value. The valuation of interest rate swaps is included in long-term debt on the accompanying consolidated balance sheets. The valuation of foreign currency forward exchange contracts at March 31, 2024, resulted in a net asset and is included in other current assets on the accompanying consolidated balance sheet.     At March 31, 2024, the Company had foreign currency contracts in the form of forward exchange contracts with notional amounts of approximately U.S. $78.0 million and GB £4.7 million which all have maturities of less than one year.

v3.24.1.u1

Leases:	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases:	7. Leases:   The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.   In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.   As of March 31, 2024, the weighted average remaining lease term was 4.8 years and the weighted average discount rate used to determine the operating lease liability was 3%. Rental expense related to operating leases was $1.6 million and $1.4 million for the three months ended March 31, 2024 and 2023, respectively. Operating lease payments included in operating cash flows totaled $1.5 million and $1.3 million for the three months ended March 31, 2024 and 2023, respectively. There were $0.2 million of noncash additions to operating lease assets for the three months ended March 31, 2024 and no noncash additions to operating lease assets for the three months ended March 31, 2023.

v3.24.1.u1

Share-Based Payments:	3 Months Ended
	Mar. 31, 2024
Equity:
Share-Based Payments:	8. Share-Based Payments:   The Company maintains a stock option program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to five-year period. The fair value of shares vested during the three months ended March 31, 2024 and 2023 aggregated $0.04 million and $0.09 million, respectively. Compensation cost, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options. The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:       Number of Shares     Weighted Average Grant-Date Fair Value   Nonvested options – beginning of period     122,100     $ 24.47   Nonvested options granted     —       —   Nonvested options vested or forfeited     (3,140 )   $ 11.86   Nonvested options – end of period     118,960     $ 24.80        Share-based payment expense decreased income before income taxes by $0.59 million and $0.63 million for the three months ended March 31, 2024 and 2023, respectively, and decreased income attributable to Inter Parfums, Inc. by $0.39 million and $0.43 million for the three months ended March 31, 2024 and 2023, respectively.   The following table summarizes stock option information as of March 31, 2024:       Shares     Weighted Average Exercise Price                 Outstanding at January 1, 2024     308,970     $ 86.52   Options forfeited     (140 )     73.09   Options exercised     (18,980 )     69.87                     Outstanding at March 31, 2024     289,850     $ 87.62                     Options exercisable     170,890     $ 70.60   Options available for future grants     537,505             As of March 31, 2024, the weighted average remaining contractual life of options outstanding is 2.69 years (0.5 years for options exercisable); the aggregate intrinsic value of options outstanding and options exercisable is $15.7 million and $11.9 million, respectively; and unrecognized compensation cost related to stock options outstanding aggregated $2.7 million.   Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:   (In thousands)   March 31, 2024     March 31, 2023                 Cash proceeds from stock options exercised   $ 1,326     $ 4,929   Tax benefits     220       780   Intrinsic value of stock options exercised     1,375       5,403     There were no options granted during the three months ended March 31, 2024 and March 31, 2023.   Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors maintain its current payout ratio as a percentage of earnings.   In March 2022, Interparfums SA, our 72% owned French Subsidiary, approved a plan to grant an aggregate of 88,400 shares of its stock to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in June 2025.   The fair value of the grant had been determined based on the quoted stock price of Interparfums SA shares as reported by the Euronext on the date of grant. The estimated number of shares to be distributed of 93,612 has been determined taking into account employee turnover. The aggregate cost of the grant of approximately $4.2 million will be recognized as compensation cost on a straight-line basis over the requisite three and a quarter year service period.       In order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of March 31, 2024 the Company acquired 87,609 shares at an aggregate cost of $4.1 million.   All share purchases and issuances have been classified as equity transactions on the accompanying balance sheet.

v3.24.1.u1

Net Income Attributable to Inter Parfums, Inc. Common Shareholders:	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Income Attributable to Inter Parfums, Inc. Common Shareholders:	9. Net Income Attributable to Inter Parfums, Inc. Common Shareholders:   Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.   The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:       Three months ended   (In thousands)   March 31,       2024     2023   Numerator:             Net income attributable to Inter Parfums, Inc.   $ 41,048     $ 54,068   Denominator:                 Weighted average shares     32,041       32,018   Effect of dilutive securities:                 Stock options     225       141   Denominator for diluted earnings per share     32,266       32,159                     Earnings per share:                 Net income attributable to Inter                 Parfums, Inc. common shareholders:                 Basic   $ 1.28     $ 1.69   Diluted     1.27       1.68     Not included in the above computations are the effect of antidilutive potential common shares which consist of outstanding options to purchase 0.05 million shares of common stock for the three months ended March 31, 2024. There were no antidilutive potential common shares outstanding for the three months ended March 31, 2023.

v3.24.1.u1

Segment and Geographic Areas:	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Segment and Geographic Areas:	10. Segment and Geographic Areas:   The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European based operations and United States based operations primarily represent the sale of prestige brand name fragrances.   Information on our operations by segments is as follows:   (In thousands)   Three months ended March 31,       2024     2023   Net sales:                 United States   $ 95,768     $ 81,454   Europe     230,957       230,269   Eliminations of intercompany sales     (2,762 )     —                         $ 323,963     $ 311,723                     Net income attributable to Inter Parfums, Inc.:                 United States   $ 9,527     $ 10,343   Europe     32,685       43,725   Eliminations     (1,164 )     —       $ 41,048     $ 54,068         March 31,     December 31,       2024     2023   Total Assets:                 United States   $ 337,876     $ 344,341   Europe     1,069,258       1,066,684   Eliminations     (57,958 )     (41,696 )     $ 1,349,176     $ 1,369,329

v3.24.1.u1

Inventories: (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories consist of the following:	Inventories consist of the following:   (In thousands)   March 31, 2024     December 31, 2023   Raw materials and component parts   $ 178,678     $ 158,733   Finished goods     221,531       213,126                         $ 400,209     $ 371,859

v3.24.1.u1

Fair Value Measurement: (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.	The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.                                                 Fair Value Measurements at March 31, 2024       Total     Quoted Prices in Active Markets for Identical Assets (Level 1)     Significant Other Observable Inputs (Level 2)     Significant Unobservable Inputs (Level 3)   Assets:                         Short-term investments   $ 76,078     $ 10,379     $ 65,699     $ —   Interest rate swaps     4,096       —       4,096       —   Foreign currency forward exchange contracts not accounted for using hedge accounting     395       —       395       —   Foreign currency forward exchange contracts accounted for using hedge accounting     305     $ —     305       —                                         $ 80,874     $ 10,379     $ 70,495     $ —                                                   Fair Value Measurements at December 31, 2023       Total     Quoted Prices in Active Markets for Identical Assets (Level 1)     Significant Other Observable Inputs (Level 2)     Significant Unobservable Inputs (Level 3)   Assets:                         Short-term investments   $ 94,304     $ 12,868     $ 80,614     $ 822   Interest rate swaps     3,909       —       3,909       —   Foreign currency forward exchange contracts not accounted for using hedge accounting     359       —       359       —   Foreign currency forward exchange contracts accounted for using hedge accounting     1,533       —       1,533       —                                         $ 100,105     $ 12,868     $ 86,415     $ 822

v3.24.1.u1

Share-Based Payments: (Tables)	3 Months Ended
	Mar. 31, 2024
Equity:
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:	The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:       Number of Shares     Weighted Average Grant-Date Fair Value   Nonvested options – beginning of period     122,100     $ 24.47   Nonvested options granted     —       —   Nonvested options vested or forfeited     (3,140 )   $ 11.86   Nonvested options – end of period     118,960     $ 24.80
The following table summarizes stock option information as of March 31, 2024:	The following table summarizes stock option information as of March 31, 2024:       Shares     Weighted Average Exercise Price                 Outstanding at January 1, 2024     308,970     $ 86.52   Options forfeited     (140 )     73.09   Options exercised     (18,980 )     69.87                     Outstanding at March 31, 2024     289,850     $ 87.62                     Options exercisable     170,890     $ 70.60   Options available for future grants     537,505
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:	Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:   (In thousands)   March 31, 2024     March 31, 2023                 Cash proceeds from stock options exercised   $ 1,326     $ 4,929   Tax benefits     220       780   Intrinsic value of stock options exercised     1,375       5,403

v3.24.1.u1

Net Income Attributable to Inter Parfums, Inc. Common Shareholders: (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:	The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:       Three months ended   (In thousands)   March 31,       2024     2023   Numerator:             Net income attributable to Inter Parfums, Inc.   $ 41,048     $ 54,068   Denominator:                 Weighted average shares     32,041       32,018   Effect of dilutive securities:                 Stock options     225       141   Denominator for diluted earnings per share     32,266       32,159                     Earnings per share:                 Net income attributable to Inter                 Parfums, Inc. common shareholders:                 Basic   $ 1.28     $ 1.69   Diluted     1.27       1.68

v3.24.1.u1

Segment and Geographic Areas: (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Information on our operations by segments is as follows:	Information on our operations by segments is as follows:   (In thousands)   Three months ended March 31,       2024     2023   Net sales:                 United States   $ 95,768     $ 81,454   Europe     230,957       230,269   Eliminations of intercompany sales     (2,762 )     —                         $ 323,963     $ 311,723                     Net income attributable to Inter Parfums, Inc.:                 United States   $ 9,527     $ 10,343   Europe     32,685       43,725   Eliminations     (1,164 )     —       $ 41,048     $ 54,068         March 31,     December 31,       2024     2023   Total Assets:                 United States   $ 337,876     $ 344,341   Europe     1,069,258       1,066,684   Eliminations     (57,958 )     (41,696 )     $ 1,349,176     $ 1,369,329

v3.24.1.u1

Recent Agreements: (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2024 EUR (€)	Mar. 31, 2024 EUR (€)	Dec. 31, 2022	Apr. 30, 2021
Business Acquisition [Line Items]
Purchase price, period cost	$ 151,000,000	€ 139,000,000
Acquisition costs, period cost	3,100,000
Cash held in escrow is included in other assets	$ 0
Long-term debt, term	10 years		10 years	4 years	10 years
Long-term line of credit	$ 129,700,000		€ 120,000,000
Description of debt instrument interest rate terms	one-month Euribor plus 0.75%	one-month Euribor plus 0.75%
Debt instrument, face amount | €			€ 80,000,000
Variable interest rate	2.00%		2.00%
Fixed interest rate	1.10%		1.10%
Minimum [Member]
Business Acquisition [Line Items]
Depreciated over a range	7 years		7 years
Maximum [Member]
Business Acquisition [Line Items]
Depreciated over a range	50 years		50 years
Land [Member]
Business Acquisition [Line Items]
Purchase price, period cost	$ 61,900,000	€ 57,000,000
Building [Member]
Business Acquisition [Line Items]
Purchase price, period cost	$ 88,800,000	€ 82,000,000
Interparfums SA [Member]
Business Acquisition [Line Items]
Ownership percentage					72.00%
Roberto Cavalli [Member]
Business Acquisition [Line Items]
Description of recent agreement	The license became effective in July 2023 and will last for 6.5 years.	The license became effective in July 2023 and will last for 6.5 years.

v3.24.1.u1

Inventories consist of the following: (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and component parts	$ 178,678	$ 158,733
Finished goods	221,531	213,126
Inventories	$ 400,209	$ 371,859

v3.24.1.u1

The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets:
Short-term investments	$ 76,078	$ 94,304
Interest rate swaps	4,096	3,909
Foreign currency forward exchange contracts not accounted for using hedge accounting	395
Foreign currency forward exchange contracts not accounted for using hedge accounting	305	359
	80,874	100,105
Foreign currency forward exchange contracts accounted for using hedge accounting		1,533
Fair Value, Inputs, Level 1 [Member]
Assets:
Short-term investments	10,379	12,868
Interest rate swaps
Foreign currency forward exchange contracts not accounted for using hedge accounting
Foreign currency forward exchange contracts not accounted for using hedge accounting
	10,379	12,868
Foreign currency forward exchange contracts accounted for using hedge accounting
Fair Value, Inputs, Level 2 [Member]
Assets:
Short-term investments	65,699	80,614
Interest rate swaps	4,096	3,909
Foreign currency forward exchange contracts not accounted for using hedge accounting	395
Foreign currency forward exchange contracts not accounted for using hedge accounting	305	359
	70,495	86,415
Foreign currency forward exchange contracts accounted for using hedge accounting		1,533
Fair Value, Inputs, Level 3 [Member]
Assets:
Short-term investments		822
Interest rate swaps
Foreign currency forward exchange contracts not accounted for using hedge accounting
Foreign currency forward exchange contracts not accounted for using hedge accounting
		822
Foreign currency forward exchange contracts accounted for using hedge accounting

v3.24.1.u1

Derivative Financial Instruments: (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2024 GBP (£)	Mar. 31, 2023 USD ($)	Mar. 31, 2023 EUR (€)	Dec. 31, 2022	Apr. 30, 2021 USD ($)	Apr. 30, 2021 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Loan amount			$ 54,100,000	€ 50,000,000		$ 129,700,000	€ 120,000,000
Long-term debt, term	10 years	10 years			4 years	10 years	10 years
Derivative swap interest rate			2.00%	2.00%		1.10%	1.10%
Interest Rate Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Loan amount | €							€ 80,000,000
Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Loan amount | £		£ 2,500,000
Forward exchange contracts | $	$ 61,000,000
Maturity of foreign currency	1 year

v3.24.1.u1

Leases: (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating lease, weighted average remaining lease term	5 years 6 months
Operating lease, weighted average discount rate, percent	3.00%
Operating leases, rent expense, net	$ 1,600,000	$ 1,400,000
Operating Lease, Payments	1,500,000	1,300,000
Noncash additions to operating lease assets	$ 0	$ 0

v3.24.1.u1

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024: (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Equity:
Nonvested options - beginning of year | shares	122,100
Weighted average grant date fair value, beginning of year | $ / shares	$ 24.47
Nonvested options granted | shares
Weighted average grant date fair value, granted | $ / shares
Nonvested options vested or forfeited | shares	(3,140)
Weighted average grant date fair value, vested or forfeited | $ / shares	$ 11.86
Nonvested options - end of year | shares	118,960
Weighted average grant date fair value, end of year | $ / shares	$ 24.80

v3.24.1.u1

The following table summarizes stock option information as of March 31, 2024: (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Equity:
Options shares under option - beginning of year	308,970
Weighted average exercise price shares under option - beginning of year | $ / shares	$ 86.52
Options forfeited	(140)
Weighted average exercise price options forfeited | $ / shares	$ 73.09
Options exercised	(18,980)
Weighted average exercise price options exercised | $ / shares	$ 69.87
Options shares under option - end of year	289,850
Weighted average exercise price shares under option - end of year | $ / shares	$ 87.62
Options exercisable	170,890
Weighted average exercise price options exercisable | $ / shares	$ 70.60
Options granted	537,505

v3.24.1.u1

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows: (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Equity:
Cash proceeds from stock options exercised	$ 1,326	$ 4,929
Tax benefits	220	780
Intrinsic value of stock options exercised	$ 1,375	$ 5,403

v3.24.1.u1

Share-Based Payments: (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Subsidiary or Equity Method Investee [Line Items]
Income before income taxes	$ 70,053,000	$ 92,586,000
Share-based payment arrangement, expense	$ 390,000	$ 430,000
Weighted average remaining contractual life of options outstanding (in years)	2 years 1 month 24 days
Weighted average remaining contractual life of options exercisable (in years)	4 months 2 days
Aggregate intrinsic value of options outstanding and options outstanding	$ 15,700,000
Aggregate intrinsic value of options outstanding and options exercisable	11,900,000
Unrecognized compensation cost	$ 2,700,000
Options granted	0	0
Interparfums SA Subsidiary [Member]
Subsidiary or Equity Method Investee [Line Items]
Recognized as compensation cost	$ 4,200,000
Interparfums SA Subsidiary [Member] | Employees [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of share distributed	93,612
Recognized as compensation cost	$ 4,100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized	87,609
Equity Option [Member]
Subsidiary or Equity Method Investee [Line Items]
Fair value of shares vested	$ 40,000.00	$ 90,000.00
Minimum [Member] | Equity Option [Member]
Subsidiary or Equity Method Investee [Line Items]
Options vesting period	4 years
Maximum [Member] | Equity Option [Member]
Subsidiary or Equity Method Investee [Line Items]
Options vesting period	5 years

v3.24.1.u1

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share [Abstract]
Net income attributable to Inter Parfums, Inc (in dollars)	$ 41,048	$ 54,068
Weighted average shares	32,041	32,018
Stock options	225	141
Denominator for diluted earnings per share	32,266	32,159
Basic (in dollars per share)	$ 1.28	$ 1.69
Diluted (in dollars per share)	$ 1.27	$ 1.68

v3.24.1.u1

Information on our operations by segments is as follows: (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 323,963	$ 311,723
Net income attributable to Inter Parfums, Inc	41,048	54,068
Total assets	1,349,176	1,369,329	$ 1,369,329
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	95,768	81,454
Net income attributable to Inter Parfums, Inc	9,527	10,343
Total assets	337,876	344,341
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	230,957	230,269
Net income attributable to Inter Parfums, Inc	32,685	43,725
Total assets	1,069,258	1,066,684
Eliminations [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	(2,762)
Net income attributable to Inter Parfums, Inc	(1,164)
Total assets	$ (57,958)	$ (41,696)

---